Literature DB >> 9572317

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.

M R Griffin1.   

Abstract

Nonaspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently used drugs in many countries. Use of the majority of NSAIDs increases with age, primarily for symptoms associated with osteoarthritis and other chronic musculoskeletal conditions. Population-based studies have shown that, on any given day, 10-20% of elderly people (> or = 65 years old) have a current or recent NSAID prescription. Over a 6-month period in Alberta, Canada, 27% of elderly people were prescribed NSAIDs. Furthermore, in Tennessee (USA), 40% of elderly people received at least one NSAID prescription annually, and 6% had NSAID prescriptions for > 75% of the year. NSAIDs cause a wide variety of side-effects. The most clinically important side-effects are upper gastrointestinal tract dyspepsia, peptic ulceration, hemorrhage, and perforation, leading to death in some patients. Gastrointestinal side-effects are common; the most common NSAID-associated side-effect is epigastric pain/indigestion. Gastrointestinal side-effects are also a frequent reason both for withdrawal of NSAIDs and for co-treatment with another drug. Indeed, in two population-based studies of people aged > or = 65 years, the use of agents to prevent peptic ulcers or relieve dyspepsia was nearly twice as common in regular NSAID users (20-26%) than in non-NSAID users (11%). In Alberta, Canada, it has been estimated that NSAID use accounts for 28% of all prescriptions for anti-ulcer drugs in people aged at least 65 years. Many studies have now shown that NSAIDs increase the risk of peptic ulcer complications by 3-5-fold, and in several different populations it has been estimated that 15-35% of all peptic ulcer complications are due to NSAIDs. In the United States alone, there are an estimated 41,000 hospitalizations and 3,300 deaths each year among the elderly that are associated with NSAIDs. Factors that increase the risk of serious peptic ulcer disease include older age, history of peptic ulcer disease, gastrointestinal hemorrhage, dyspepsia, and/or previous NSAID intolerance, as well as several measures of poor health.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572317     DOI: 10.1016/s0002-9343(97)00207-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  57 in total

Review 1.  Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity. A multinational perspective.

Authors:  C Chevat; B M Peña; M J Al; F F Rutten
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Rheumatology: 4. Acute monoarthritis.

Authors:  J Cibere
Journal:  CMAJ       Date:  2000-05-30       Impact factor: 8.262

3.  Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.

Authors:  V Bongard; S Ménard-Taché; H Bagheri; K Kabiri; M Lapeyre-Mestre; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

Review 4.  Adverse drug reactions: back to the future.

Authors:  Munir Pirmohamed; B Kevin Park
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

5.  Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy.

Authors:  Maria Chiara Silvani; Domenico Motola; Elisabetta Poluzzi; Ambrogio Bottoni; Fabrizio De Ponti; Alberto Vaccheri; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2006-01-17       Impact factor: 2.953

6.  L-Theanine healed NSAID-induced gastric ulcer by modulating pro/antioxidant balance in gastric ulcer margin.

Authors:  Sirshendu Chatterjee; Ananya Chatterjee; Surmi Roy; Biswajit Bera; Sandip K Bandyopadhyay
Journal:  J Nat Med       Date:  2014-07-01       Impact factor: 2.343

7.  Epidemiology of peptic ulcer disease in Wuhan area of China from 1997 to 2002.

Authors:  Wei-Guo Dong; Chun-Sheng Cheng; Shao-Ping Liu; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 8.  Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.

Authors:  Shaoheng Zhang; Qing Qing; Yang Bai; Hua Mao; Wei Zhu; Qikui Chen; Yali Zhang; Ye Chen
Journal:  Dig Dis Sci       Date:  2013-02-28       Impact factor: 3.199

9.  [Chronic musculoskeletal conditions and comorbidities in primary care settings].

Authors:  Catherine Hudon; Martin Fortin; Hassan Soubhi
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

10.  Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.

Authors:  Krishanu Sengupta; Alluri V Krishnaraju; Amar A Vishal; Artatrana Mishra; Golakoti Trimurtulu; Kadainti V S Sarma; Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Int J Med Sci       Date:  2010-11-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.